Asiri Surgical Hospital PLC
AMSL.N0000Healthcare · Hospital/Nursing Management
Annual fundamentals
| Year | Revenue | Net profit | EPS |
|---|---|---|---|
| 2025 | Rs 7.2B | Rs 373.7M | 0.50 |
| 2024 | Rs 6.6B | Rs 746.3M | 1.24 |
| 2023 | Rs 5.6B | Rs 640.0M | 1.21 |
| 2022 | Rs 5.8B | Rs 1.2B | 2.36 |
| 2021 | Rs 4.2B | Rs 859.7M | 1.63 |
| 2020 | Rs 3.7B | Rs 433.1M | 0.82 |
| 2019 | Rs 3.5B | Rs 366.5M | 0.69 |
Recent dividends
- 2025 · first interimRs 0.30
- 2022 · second interimRs 0.90
- 2022 · first interimRs 1.20
- 2021 · second interimRs 0.60
- 2021 · first interimRs 0.25
- 2019Rs 0.50
- 2018Rs 0.85
- 2017Rs 0.35
About Asiri Surgical Hospital PLC
Asiri Surgical Hospital (ASH) is a private sector surgical hospital in Sri Lanka offering a broad range of surgical disciplines from routine procedures to complex surgeries. The hospital operates 155+ beds, records over 200,000 channellings and performs 8,800+ surgeries, delivering care through state-of-the-art operating theatres, advanced diagnostic facilities and modern medical technology. ASH provides end-to-end surgical care spanning pre-surgical consultations and diagnostic evaluations through personalised post-operative care, supported by stringent protocols for infection control and patient safety. The hospital emphasises continual investment in new medical technologies and surgical techniques to maintain clinical standards. The organisation highlights several centres of excellence, including cardiology, oncology, orthopedics, urology, neurology, gastroenterology and organ transplantation. The wider Asiri Hospital Holdings group describes group-level environmental and social initiatives such as waste management, energy-efficiency upgrades and community outreach programs.
AI analysis
neutralProfitability has rebuilt, with the latest quarter’s net margin at 13.4%, yet the share trades near book at P/B 0.94 after a -46.0% three-month slide.
Read the full report (Aug 4, 2026) →News sentiment
Describes news flow, not a forecastNo scored news in the last 30 days.
Softlogic Holdings PLC appointed Imran Furkan as an Independent Non-Executive Director effective 29 August 2025. Furkan, CEO of Tresync (Australia), has prior board roles including at Odel, Asiri Surgical Hospital and Maharaja Foods and experience across health, retail and IT.
Asiri Hospital Holdings PLC and Asiri Surgical Hospital PLC appointed Kalum de Silva as a Non-Executive, Independent Director. He has over 20 years' experience in private equity, M&A and growth advisory, bringing expertise in funding, governance and scaling businesses.
Healthcare sector: what is happening
Last 30 days to Aug 4, 2026SLPMA dominated sector news, urging a long-term government buyback to back local pharma manufacturing, quicker raw-material import approvals and stable incentives, plus a national push to make pharmaceuticals an export engine through a task force and faster regulation. Cross-border activity featured a 31-member Indian delegation on 8-10 July for B2B sessions including pharma. Colombo Port City moved to seek operators for an international hospital. Cybersecurity risks to hospitals gained attention.
The stories behind it
Auto-generated from 8 sector news articles over 30 days. Not investment advice. 2 more stories on the sentiment page.